Advertisement
Screener

ANIXA BIOSCIENCES, INC. (ANIX) Long-term Debt, Gross

2.8 / 5 stars · 68/120 Roast Me

ANIXA BIOSCIENCES, INC. Long-term Debt, Gross

ANIXA BIOSCIENCES, INC. (ANIX) had Long-term Debt, Gross of $2.45 million as of 2014-10-31, per its 10-K filed 2015-01-29.

Discontinued › Notes › Debt › Debt Instruments

us-gaap:DebtInstrumentCarryingAmount · last filed 2015-01-29

  • 2014-10-31: Long-term Debt, Gross $2.45M.
  • 2014-07-31: Long-term Debt, Gross $2.45M.
  • 2014-04-30: Long-term Debt, Gross $2.45M.
  • 2013-10-31: Long-term Debt, Gross $259.85K.
Period endLong-term Debt, Gross
2014-10-31$2.45M
10-K · filed 2015-01-29
2014-07-31$2.45M
10-Q · filed 2014-09-15
2014-04-30$2.45M
10-Q · filed 2014-06-16
2013-10-31$259.85K
10-K · filed 2015-01-29
2013-07-31$259.85K
10-Q/A · filed 2013-09-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
ProMIS Neurosciences Inc. (PMN)$0.102B
Rallybio Corp (RLYB)United States$0.089B
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92